https://www.thebodypro.com/article/raltegravir-superior-to-boosted-protease-inhibitor
First-Line HIV TreatmentConference Coverage

Raltegravir Superior to Boosted Protease Inhibitors as First-Line Treatment

    Josep M. Llibre, M.D., Ph.D.

    Josep M. Llibre, M.D., Ph.D.

    Benjamin Young, M.D., Ph.D.

    Benjamin Young, M.D., Ph.D.

    Ben Young, M.D., Ph.D., is a highly regarded HIV physician-researcher at the forefront of efforts to establish better coordinated care for people living with HIV. He was a Q&A expert and writer on TheBody for nearly 20 years, leaving in 2018.